DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis

Gliomas, the most frequent type of primary tumor of the central nervous system in adults, results in significant morbidity and mortality. Despite the development of novel, complex, multidisciplinary, and targeted therapies, glioma therapy has not progressed much over the last decades. Therefore, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Vedunova, Maria, Turubanova, Victoria, Vershinina, Olga, Savyuk, Maria, Efimova, Iuliia, Mishchenko, Tatiana, Raedt, Robrecht, Vral, Anne, Vanhove, Christian, Korsakova, Daria, Bachert, Claus, Coppieters, Frauke, Agostinis, Patrizia, Garg, Abhishek D., Ivanchenko, Mikhail, Krysko, Olga, Krysko, Dmitri V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767932/
https://www.ncbi.nlm.nih.gov/pubmed/36539408
http://dx.doi.org/10.1038/s41419-022-05514-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767932/
https://www.ncbi.nlm.nih.gov/pubmed/36539408
http://dx.doi.org/10.1038/s41419-022-05514-0

Ejemplares similares